Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kara DeWalt"'
Autor:
Sumanta Kumar Pal, Yulan Ingrid Lin, Bertram Yuh, Kara DeWalt, Austin Kazarian, Nicholas Vogelzang, Rebecca A Nelson
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136622 (2015)
Second-line therapy is frequently utilized for metastatic urothelial carcinoma, but there are limited data to guide this approach. While an assessment of overall survival based on registry data may not capture the impact of second- and third-line the
Externí odkaz:
https://doaj.org/article/b4bc891c132e4639bd4e086a23217980
Autor:
Sumanta K Pal, Nora Ruel, Sergio Villegas, Mark Chang, Kara DeWalt, Timothy G Wilson, Nicholas J Vogelzang, Bertram E Yuh
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94471 (2014)
Clinical guidelines suggest neoadjuvant cisplatin-based chemotherapy prior to cystectomy in the setting of muscle-invasive bladder cancer (MIBC). A creatinine clearance (CrCl) >60 mL/min is frequently used to characterize cisplatin-eligible patients,
Externí odkaz:
https://doaj.org/article/8f944fe60e8048d883e9458a7d441200
Autor:
Bertram Yuh, Sumanta K. Pal, Kara DeWalt, Nicholas J. Vogelzang, Yulan Ingrid Lin, Rebecca A. Nelson, Austin Kazarian
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 8, p e0136622 (2015)
PLoS ONE, Vol 10, Iss 8, p e0136622 (2015)
Background Second-line therapy is frequently utilized for metastatic urothelial carcinoma, but there are limited data to guide this approach. While an assessment of overall survival based on registry data may not capture the impact of second- and thi
Autor:
Bertram Yuh, Nora Ruel, Timothy G. Wilson, Kara DeWalt, Nicholas J. Vogelzang, Sumanta K. Pal, Mark Chang, Sergio Villegas
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 4, p e94471 (2014)
PLoS ONE, Vol 9, Iss 4, p e94471 (2014)
Clinical guidelines suggest neoadjuvant cisplatin-based chemotherapy prior to cystectomy in the setting of muscle-invasive bladder cancer (MIBC). A creatinine clearance (CrCl) >60 mL/min is frequently used to characterize cisplatin-eligible patients,
Publikováno v:
Journal of Clinical Oncology. 32:4548-4548